- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 5/117 - Tétrapeptides le premier amino-acide étant hétérocyclique, p. ex. Pro, His, Trp
Détention brevets de la classe C07K 5/117
Brevets de cette classe: 256
Historique des publications depuis 10 ans
|
18
|
16
|
17
|
16
|
15
|
11
|
12
|
22
|
26
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The University of British Columbia | 1520 |
8 |
| Zedira GmbH | 37 |
8 |
| Board of Regents, The University of Texas System | 5912 |
7 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2202 |
7 |
| Limited Liability Company "lifemission" | 7 |
7 |
| Eli Lilly and Company | 3880 |
6 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 979 |
5 |
| Intezyne Technologies, Inc. | 56 |
5 |
| Nissan Chemical Industries, Ltd. | 1700 |
5 |
| Palatin Technologies, Inc. | 68 |
5 |
| Bristol-myers Squibb Company | 4847 |
4 |
| Cornell Research Foundation, Inc. | 238 |
4 |
| Hangzhou DAC Biotech Co., Ltd | 103 |
4 |
| Onyx Therapeutics, Inc. | 69 |
4 |
| University of Cincinnati | 889 |
4 |
| Stealth Biotherapeutics Inc. | 168 |
4 |
| Anygen Co., Ltd. | 36 |
3 |
| City University of Hong Kong | 210 |
3 |
| Creighton University | 91 |
3 |
| Genzyme Corporation | 1303 |
3 |
| Autres propriétaires | 157 |